
summari light outbreak updat
model reflect best estim impact compani
financi analysi base convers compani
manag industri expert physician survey see note
date march physician survey
special confer call seri
follow impact china two month
return volum impact ex-china
geographi mid-march june-end return
volum catch-up prior estim
catch-up higher flow-through
impact ep given compani limit abil adjust
cost near-term overal lower estim pt
maintain overweight rate
lower estim lower revenu
ep estim primarili reflect impact
lower revenu forecast
y/i revenu forecast
y/i lower
ep forecast
y/i ep forecast
lower pt maintain
overweight rate lower pt prior
base approxim prior cash ep estim
prior histor trade premium
fargo large-cap med-tech index given abil drive
organ revenu growth toward upper end group rang
ep growth top-end despit continu trade
lowest ratio within peer group vs
group impli growth opportun fulli
reflect stock price forward multipl
peak level reflect view compani
abil drive strong organ ex-fx revenu growth high
singl digit driven growth acceler urolift
manta oper margin om expans improv free cash
flow project period maintain
overweight rate
continu page
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
compani data secur llc estim reuter
compani data secur llc estim reuter
continu previou page
portfolio mix posit effect manag headwind
modest exposur china diversifi revenu base focus treat older emergent-car
patient suffici liquid improv balanc sheet allow effect manag
headwind believ estim nearli compani portfolio non-elect
includ categori vascular access total sale intervent access total
sale much anesthesia total sale oem total sale busi
analysi show like saw manag impact china crisi given low
exposur total sale impact like upper end compani guidanc
sale ep expect notabl impact ex-china geographi
america total sale emea total sale elect procedur
either halt volum dramat reduc due pandem exampl
physician survey indic expect reduct urolift procedur crisi
also expect volum return fairli quickli within month pandem subsid
worth note base ceo liam kelli public comment appear saw impact
urolift procedur due mid-march
strengthen balanc sheet suffici liquid end total
debt cash cash equival balanc sheet net leverag ratio exit
allow compani approxim debt capac recal acquir iwg high
perform conductor within oem busi would bring net leverag
level modestli higher coupl lower adj ebitda due said suffici
liquid includ revolv estim avail approxim prior
laid goal improv profil end lrp
period compani gener repres convers
estim millionsnew estimatesold chang yoy-organ chang yoy-organ chang yoy-organ chang yoy-organ chang yoy-organ chang yoy-organ chang yoy-organ chang yoy-organ oper chang secur llc estim incorpor
exhibit net impact quarter
impact total impact total y/i report impact impact impact secur llc estim million except per share data fiscal year end decemb good gross total oper oper interest expens pre-tax incom net minor interests- net incom sharehold fulli dilut dilut ep adj sharehold growthrevenu good incom sharehold compani report factsect secur llc estim medic technolog
price target
valu approxim ep estim arriv price
target reflect premium peer reflect compani improv organ cc growth
profil om expans improv profil current trade lowest ratio
rel peer group despit potenti growth acceler provid meaning upsid
risk includ follow core busi may abl deliv state growth
goal new product ramp may fall short expect time distributor order
destock may caus earn stock price volatil depend
reimburs environ continu uptak product may becom unfavor
pois deliv high singl digit revenu mid-teen ep growth underli basi
peer large-cap med-tech index believ compani
defens natur posit well headwind notabl major product
util emerg emerg care set total sale area
well-entrench market posit also certain growth acceler urolift manta
percuv ezpla could posit deliv profit growth state goal street
found headquart wayn pa teleflex incorpor global diversifi medic
devic compani oper multipl end market sell product follow segments-
vascular access intervent surgic anesthesia intervent urolog oem
depend upon one end-market procedur growth given diversifi natur
gener sale repres organ revenu growth y/i
